Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HELICOS BIOSCIENCES CORP | 12,192,640 | reported | 18 Sept 2009 | tx 6+437,084 |
| Seres Therapeutics, Inc. | 5,875,711 | reported | 05 Jul 2022 | tx 8+17,687,131 |
| Sana Biotechnology, Inc. | 2,727,272 | reported | 12 Feb 2024 | tx 1+2,727,272 |
| Editas Medicine, Inc. | 2,039,549 | reported | 08 Feb 2016 | tx 12+4,955,316−12,883,842 |
| AGIOS PHARMACEUTICALS, INC. | 1,930,369 | reported | 23 Jun 2014 | tx 1−1,930,369 |
| Foghorn Therapeutics Inc. | 1,814,915 | reported | 22 May 2024 | tx 2+3,629,829 |
| Eleven Biotherapeutics, Inc. | 1,090,757 | reported | 15 Sept 2016 | tx 5+16,143−46,692 |
| Kaleido Biosciences, Inc. | 665,908 | reported | 04 Mar 2019 | tx 6+1,120,697−2,241,396 |
| CONCERT PHARMACEUTICALS, INC. | 563,482 | reported | 19 Feb 2014 | tx 4+623,982−3,525,500 |
| AGENUS INC | 255,274.51 | reported | 02 Apr 2007 | tx 12+56,371.64−5,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | Moderna, Inc. | 9,263 | 19.15 USD | |
| 21 May 2026 | SALE | Moderna, Inc. | 9,263 | 46.84 USD | |
| 21 May 2026 | EXERCISE | Moderna, Inc. | 9,263 | 0.00 USD | deriv |
| 06 May 2026 | GRANT_AWARD | Moderna, Inc. | 12,908 | 0.00 USD | deriv |
| 11 Dec 2025 | EXERCISE | Moderna, Inc. | 23,853 | 10.90 USD | |
| 11 Dec 2025 | SALE | Moderna, Inc. | 23,853 | 29.49 USD | |
| 11 Dec 2025 | EXERCISE | Moderna, Inc. | 23,853 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Moderna, Inc. | 25,512 | 0.00 USD | deriv |
| 31 Jul 2024 | SALE | Moderna, Inc. | 5,664 | 119.84 USD | |
| 31 Jul 2024 | SALE | Moderna, Inc. | 3,428 | 120.88 USD | |
| 31 Jul 2024 | SALE | Moderna, Inc. | 4,599 | 118.96 USD | |
| 31 Jul 2024 | SALE | Moderna, Inc. | 1,309 | 121.62 USD | |
| 24 Jul 2024 | SALE | Moderna, Inc. | 6,832 | 118.30 USD | |
| 24 Jul 2024 | SALE | Moderna, Inc. | 2,668 | 116.33 USD | |
| 24 Jul 2024 | SALE | Moderna, Inc. | 2,000 | 119.01 USD | |
| 24 Jul 2024 | SALE | Moderna, Inc. | 3,500 | 117.25 USD | |
| 17 Jul 2024 | SALE | Moderna, Inc. | 2,100 | 121.57 USD | |
| 17 Jul 2024 | SALE | Moderna, Inc. | 2,900 | 122.86 USD | |
| 17 Jul 2024 | SALE | Moderna, Inc. | 6,699 | 123.82 USD | |
| 17 Jul 2024 | SALE | Moderna, Inc. | 700 | 124.61 USD | |
| 17 Jul 2024 | SALE | Moderna, Inc. | 2,601 | 120.86 USD | |
| 10 Jul 2024 | SALE | Moderna, Inc. | 6,121 | 116.01 USD | |
| 10 Jul 2024 | SALE | Moderna, Inc. | 500 | 119.95 USD | |
| 10 Jul 2024 | SALE | Moderna, Inc. | 1,100 | 119.28 USD | |
| 10 Jul 2024 | SALE | Moderna, Inc. | 3,000 | 117.83 USD |
5 purchases reported after at least 12 months of silence — most recent on 12 Feb 2024.